Profile
Full Name
Kymera Therapeutics, Inc.Ticker Symbol
KYMRExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
August 21, 2020Indexes
Not includedWebsite
http://www.kymeratx.comEmployees
188Key Details
Price
$25.60(+2.32%)
Market cap
$1.66B(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$47.07M(-40.11% YoY)
Annual EPS
-$2.98(-18.25% YoY)
PE ratio
-
Next earnings date
May 2, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Kymera Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 13, 25 Citigroup
BuyFeb 28, 25 HC Wainwright & Co.
BuyJan 21, 25 Stephens & Co.
OverweightDec 27, 24 Leerink Partners
OutperformDec 10, 24 BTIG
BuyDec 6, 24 BMO Capital
Market PerformDec 2, 24 Wells Fargo
OverweightNov 18, 24 Stephens & Co.
OverweightNov 6, 24 Morgan Stanley
Equal-WeightNov 4, 24 UBS
BuyInstitutional Ownership
- What is the ticker symbol for Kymera Therapeutics?
- Does Kymera Therapeutics pay dividends?
- What sector is Kymera Therapeutics in?
- What industry is Kymera Therapeutics in?
- What country is Kymera Therapeutics based in?
- When did Kymera Therapeutics go public?
- Is Kymera Therapeutics in the S&P 500?
- Is Kymera Therapeutics in the NASDAQ 100?
- Is Kymera Therapeutics in the Dow Jones?
- When was Kymera Therapeutics's last earnings report?
- When does Kymera Therapeutics report earnings?
- Should I buy Kymera Therapeutics stock now?
What is the ticker symbol for Kymera Therapeutics?
The ticker symbol for Kymera Therapeutics is NASDAQ:KYMR
Does Kymera Therapeutics pay dividends?
No, Kymera Therapeutics does not pay dividends
What sector is Kymera Therapeutics in?
Kymera Therapeutics is in the Healthcare sector
What industry is Kymera Therapeutics in?
Kymera Therapeutics is in the Biotechnology industry
What country is Kymera Therapeutics based in?
Kymera Therapeutics is headquartered in United States
When did Kymera Therapeutics go public?
Kymera Therapeutics's initial public offering (IPO) was on August 21, 2020
Is Kymera Therapeutics in the S&P 500?
No, Kymera Therapeutics is not included in the S&P 500 index
Is Kymera Therapeutics in the NASDAQ 100?
No, Kymera Therapeutics is not included in the NASDAQ 100 index
Is Kymera Therapeutics in the Dow Jones?
No, Kymera Therapeutics is not included in the Dow Jones index
When was Kymera Therapeutics's last earnings report?
Kymera Therapeutics's most recent earnings report was on Feb 27, 2025
When does Kymera Therapeutics report earnings?
The next expected earnings date for Kymera Therapeutics is May 2, 2025
Should I buy Kymera Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions